Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin R Pollak

Showing results (141-150 of 167) with videos related to

Pageof 17
Sort By:
American Journal of Physiology. Cell Physiology|December 3, 2010
Biophysical properties of normal and diseased renal glomeruliHans M Wyss, Joel M Henderson, Fitzroy J Byfield, et al.
Journal of the American Society of Nephrology : JASN|November 2, 2025
Testican-2 Interaction with the Extracellular Matrix and Podocyte ProtectionDonghai Wen, Qian Zhang, Johannes van Agthoven, et al.
Pflugers Archiv : European Journal of Physiology|November 30, 2022
Apolipoprotein L1 (APOL1) cation current in HEK-293 cells and in human podocytesDavid H Vandorpe, John F Heneghan, Joshua S Waitzman, et al.
Disease Models & Mechanisms|August 5, 2021
Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney diseaseGizelle M McCarthy, Angelo Blasio, Olivia G Donovan, et al.
Journal of the American Society of Nephrology : JASN|June 17, 2020
Phosphorylation of ACTN4 Leads to Podocyte Vulnerability and Proteinuric GlomerulosclerosisDi Feng, Mukesh Kumar, Jan Muntel, et al.
Nature Genetics|June 1, 2005
TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal functionJochen Reiser, Krishna R Polu, Clemens C Möller, et al.
Journal of the American Society of Nephrology : JASN|January 10, 2015
Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical TrialJeffrey B Kopp, Cheryl A Winkler, Xiongce Zhao, et al.
The New England Journal of Medicine|March 15, 2023
Inaxaplin for Proteinuric Kidney Disease in Persons with Two <i>APOL1</i> VariantsOgo Egbuna, Brandon Zimmerman, George Manos, et al.
Science (New York, N.Y.)|July 22, 2010
Association of trypanolytic ApoL1 variants with kidney disease in African AmericansGiulio Genovese, David J Friedman, Michael D Ross, et al.
Circulation Research|January 1, 2014
Increased burden of cardiovascular disease in carriers of APOL1 genetic variantsKaoru Ito, Alexander G Bick, Jason Flannick, et al.
Pageof 17

Showing results (141-150 of 167) with videos related to

Sort By:
Pageof 17
American Journal of Physiology. Cell Physiology|December 3, 2010
Biophysical properties of normal and diseased renal glomeruliHans M Wyss, Joel M Henderson, Fitzroy J Byfield, et al.
Journal of the American Society of Nephrology : JASN|November 2, 2025
Testican-2 Interaction with the Extracellular Matrix and Podocyte ProtectionDonghai Wen, Qian Zhang, Johannes van Agthoven, et al.
Pflugers Archiv : European Journal of Physiology|November 30, 2022
Apolipoprotein L1 (APOL1) cation current in HEK-293 cells and in human podocytesDavid H Vandorpe, John F Heneghan, Joshua S Waitzman, et al.
Disease Models & Mechanisms|August 5, 2021
Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney diseaseGizelle M McCarthy, Angelo Blasio, Olivia G Donovan, et al.
Journal of the American Society of Nephrology : JASN|June 17, 2020
Phosphorylation of ACTN4 Leads to Podocyte Vulnerability and Proteinuric GlomerulosclerosisDi Feng, Mukesh Kumar, Jan Muntel, et al.
Nature Genetics|June 1, 2005
TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal functionJochen Reiser, Krishna R Polu, Clemens C Möller, et al.
Journal of the American Society of Nephrology : JASN|January 10, 2015
Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical TrialJeffrey B Kopp, Cheryl A Winkler, Xiongce Zhao, et al.
The New England Journal of Medicine|March 15, 2023
Inaxaplin for Proteinuric Kidney Disease in Persons with Two <i>APOL1</i> VariantsOgo Egbuna, Brandon Zimmerman, George Manos, et al.
Science (New York, N.Y.)|July 22, 2010
Association of trypanolytic ApoL1 variants with kidney disease in African AmericansGiulio Genovese, David J Friedman, Michael D Ross, et al.
Circulation Research|January 1, 2014
Increased burden of cardiovascular disease in carriers of APOL1 genetic variantsKaoru Ito, Alexander G Bick, Jason Flannick, et al.
Pageof 17